The Malaria Diagnostics Market is estimated to grow at a CAGR of 4.5% over the forecast period of 2023-2028, to garner a market size equivalent to $1.1 billion in 2028. The progression of malaria into a fatal disease takes only a few days. So, the need for diagnostic tests such as molecular diagnostic tests and rapid diagnostic tests is high. Additionally, this form of disease finds aggressive growth in low and underdeveloped regions with excessive rain concerns. Malaria is caused by the infected Anopheles mosquito. As per WHO Findings, nearly half of the entire world’s population is deemed at risk of this condition and an estimated 241 million people were confirmed to have malaria in 2020 (85 countries). Due to the seriousness of the condition, efforts are made by public and private players to increase the testing capacities, which in turn would aid the growth of the Malaria Diagnostics market.

Malaria Diagnostics Market Drivers

Growing Support from Leading Government and Non-government Agencies:

A superior form of support in terms of fiscal and technological aid has been witnessed in the most afflicted regions where malaria is spread. As per a recent publication, nearly 63% of the entire funding (international) for malaria assistance is provided by the Global Fund 2020. An investment of nearly $16.4 billion for malaria control programs was provided by the same organization. This also aided in nearly 148 million case treatments.

For More Queries About "Malaria Diagnostics Market" @

Tremendous Disease Burden Assisted by Alleviated Testing Capacity:

The disease burden of malaria runs incredibly high in tropical and under-developed regions. Additionally, the risk population is high in the regions which require superior care and diagnosis. Critically, the Global Fund predicts nearly 70% more confirmed cases during 2002-2020, had there been no active control present. Additionally, authorities are increasing the budgetary grants instead of the disease burden which positively impacts market growth.

Product Launch and Collaboration

In October 2022, NOUL - a Korean Medical Diagnostic Company, signed an MoU with Institute Pasteur Cameroon to strengthen the overall malaria diagnosis in Central Africa. 
In February 2022, KEMRI or Kenya Medical Research Institute launched a rapid diagnostic test for malaria detection.

The Major Players in the Market

The Major Players in the Malaria Diagnostic Market include Access Bio Inc., Abbott Labs, BioMeriux SA, Ortho Clinical Diagnostics, Thermofisher Scientific, Premier Medical Corporation, Siemens Healthineers, Bio-Rad Labs, KEMRI and Adva Care Pharma.

To request for a quote, provide your details in the below link:

Media Contact:
Mr. Venkat Reddy
Sales Manager
Contact Sales: +1-970-236-3677

About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.